- Preeti P, Ranjan M, Pham D, Bueno JL, Resende MM, Scheurer ME, Amos CI, Cheng C#, Li A#. Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort. J Thromb Haemost 2026 May 8:S1538-7836(26)00280-1. doi: 10.1016/j.jtha.2026.04.029. Epub ahead of print. PMID: 42107713; PMCID: PMC13197987 [#co-senior authors, original work]
- Boyne A, Zhou E, Li A. Automated Identification of Cancer-Associated Thrombosis Events via Natural Language Processing: A Systematic Review of the Literature. Bleeding Thromb Vasc Biol 2026;5(Suppl 1):437. PMID: 42158042; PMCID: PMC13183410 [review]
- Jiang JY, Li A, Romero A, Flowers CR, Nze C. Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review. Oncologist 2025;30(6):oyaf180. PMID: 40554671; PMCID: PMC12207873 [original work]
- Saadatagah S, Kim RB, Sukumar S, Uddin MM, Folsom AR, Cushman M, Tang W, Natarajan P, Ballantyne CM, Lutsey PL, Li A. Clonal hematopoiesis of indeterminate potential and incidence of venous thromboembolism in older adults. J Thromb Haemost 2025;23(7):2235-2241. PMID: 40252845; PMCID: PMC12207847 [original work]
- Kim RB#, Ryu, JH#, Guffey D, Zhou E, Ranjan M, Ma S, La J, Fillmore NR, Li A. Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare system. J Thromb Haemost 2025;23(5):1539-1550. PMID: 39909143. PMCID: PMC12043410 [#co-first authors, original work]
- Ma S#, Jiang JY#, Kim RB, Chiang E, Theng Tiong JW, Ryu J, Guffey D, Bandyo R, Dowst H, Swinnerton KN, Fillmore NR, La J, Li A. Circulating tumor DNA predicts venous thromboembolism in patients with cancers. J Thromb Haemost 2025;23(1):139-148. PMID: 39341370. PMCID: PMC12045112 [#co-first authors, original work]
- Kim RB, Zhou E, Swinnerton KN, La J, Ma S, Ranjan M, Do NV, Brophy MT, Fillmore NR, Li A. Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer ºÚÁÏÉçÇø Systems in the United States. J Racial Ethn Health Disparities 2025;12(4):2646-2654. PMID: 38955957; PMCID: PMC11693772 [original work]
- Jiang JY, Nze C, Guffey D, Kim R, Oluyomi AO, Rosales O, Bandyo R, Diamond A, Rivero GA, Miller-Chism CN, Udden MM, Mims MP, Teegavarapu PS, Li A#, Flowers CR#. Clinical Outcomes of Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma in a County Hospital System. Blood Neoplasia 2024;1(3):100020. PMID: 40453060; PMCID: PMC12082142 [#co-senior authors, original work]
- Ma S, La J, Swinnerton KN, Guffey D, Bandyo R, De Las Pozas G, Hanzelka K, Xiao X, Rojas-Hernandez CM, Amos CI, Chitalia V, Ravid K, Merriman KW, Flowers CR, Fillmore N#, Li A#. Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Am J Hematol 2024;99(7):1230-1239. PMID: 38654461; PMCID: PMC11166507 [#co-senior authors, original work]
- Shang H, Jiang JY, Guffey D, Novoa F, Bandyo R, Ma S, Li A. Natural History of Cancer-Associated Splanchnic Vein Thrombosis. J Thromb Haemost. 2024:S1538-7836(24)00060-6. doi: 10.1016/j.jtha.2024.01.019. PMID: 38309433. [original work]
- Kim R#, Li A#, Park K, et al. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events Comparing East Asians with Westerners. JACC: Asia, 2023, ISSN 2772-3747. https://doi.org/10.1016/j.jacasi.2023.07.008 [#co-first authors, original work]
- Ma S, Bhar S, Guffey D, Kim RB, Jamil M, Amos CI, Lee SJ, Hingorani SR, Sartain SE#, Li A#. Prospective clinical and biomarker validation of the ASTCT consensus definition for transplant-associated thrombotic microangiopathy (TA-TMA). Transplant Cell Ther 2023 Aug 17;S2666-6367(23)01472-0. doi: 10.1016/j.jtct.2023.08.015. PMID: 37597686 [#co-senior authors, original work]
- Avery J, Guffey D, Ma S, Basom R, Lee SJ, Garcia DA, Rojas Hernandez CM, Li A#, Martens KL#. Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation. Thromb Res 2023;229:1-6. PMID: 37356171. PMCID: PMC10527315 [#co-senior authors, original work]
- Martens KL#, Li A#, La J, May SB, Swinnerton KN, Tosi H, Elbers DC, Do NV, Brophy MT, Gaziano JM, Lotfollahzadeh S, Chitalia V, Ravid K, Fillmore NR. Epidemiology of venous thromboembolism in patients with solid and hematologic malignancies in the United States. JAMA Netw Open 2023;6(6):e2317945. PMID: 37306999. PMCID: PMC10261992 [#co-first authors, original work]
- Zhang Z, Hong W, Wu Q, Tsavachidis S, Li JR, Amos CI, Cheng C, Sartain SE, Afshar-Kharghan V, Dong JF, Bhatraju P, Martin PJ, Makar RS, Bendapudi PK, Li A. Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res 2023;225:39-46. PMID: 36948020. PMCID: PMC10147584 [original work]
- Dima D#, Li A#, Granat LM, Dhillon P, Chamseddine F, Wei W, Samaras CJ, Valent J, Anwer F and Khouri J. External Validation of the SAVED Score for Venous Thromboembolism Risk Stratification in Patients with Multiple Myeloma Receiving Immunomodulatory Drugs. Br J Haematol 2023;201(2):280-284. PMID: 36604838 [#co-first authors, original work]
- da Costa WL, Guffey D, Oluyomi A, Bandyo R, Rosales O, Wallace CD, Granada C, Riaz N, Fitzgerald M, Garcia DA, Carrier M, Amos CI, Flowers CR, Li A. Patterns of venous thromboembolism risk, treatment, and outcomes among patients with cancer from uninsured and vulnerable populations. Am J Hematol 2022;97(8):1044-1054. PMID: 35638475 [original work]
- Li A#, Martens KL#, Nguyen D, Basom R, Rondon G, Jin S, Young E, Amos CI, Lee SJ, Davis C, Garcia DA, Champlin R, Shpall E, Kebriaei P#, Rojas Hernandez CM#. External Validation of the HIGH-2-LOW Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant. Am J Hematol 2022;97(6):740-748. PMID: 35266218 [original work]
- Van Benschoten V, Roy C, Gupta R, Ouellette L, Hingorani S, Li A. Incidence and risk factors of transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis. Transplant Cell Ther 2022;28(5):266.e1-266.e8. PMID: 35042011 [original work]
- Martens KL, Amos CI, Hernandez CR, Kebriaei P, da Costa WL, Basom R, Davis C, Kesten M, Carrier M, Garcia DA, Lee SJ, Li A. Impact of anticoagulation on recurrent thrombosis and bleeding after hematopoietic cell transplantation. Am J Hematol 2021;96(9):1137-1146. PMID: 34097772. [original work]
- Martens KL, da Costa Jr WL, Amos CI, Davis C, Kesten M, Lee SJ, Zakai NA, Garcia DA, Li A. HIGH-2-LOW Risk Model to Predict Venous Thromboembolism in Allogeneic Transplant Patients After Platelet Engraftment. Blood Adv 2021;5:167-175. PMID: 33570631; PMCID: PMC7805312 [original work]
- Desai A, Gupta R, Advani S, Ouellette L, Kuderer NM, Lyman GH, Li A. Mortality in Hospitalized Patients with Cancer and COVID-19: A Systematic Review and Meta-Analysis of Cohort Studies. Cancer 2020;127(9):1459-1468. PMID: 33378122. [original work]
- Khalighi PR, Martens KL, White AA, Li S, Silgard E, Frieze D, Garcia DA, Li A. Utilization patterns and clinical outcomes of rasburicase administration according to tumor risk stratification. J Oncol Pharm Pract 2020;26(3)529-535. PMID: 31167612 [original work]
- Martens KL, Khalighi PR, Li S, White AA, Silgard E, Frieze D, Estey E, Garcia DA, Hingorani S, Li A. Comparative effectiveness of rasburicase versus allopurinol for cancer patients with renal dysfunction and hyperuricemia. Leuk Res 2020;89:106298. PMID: 31945598 [original work]
